Unrestricted somatic stem cells as vehicle for nerve growth factor gene transfer

References

• Bartkowska K, Turlejski K, Djavadian RL. Neurotrophins and their receptors in early development of the mammalian nervous system. Acta Neurobiol Exp (Wars). 2010;70:454–67.
   PubMed Web of Science ®Google Scholar
• Terenghi G. Peripheral nerve regeneration and neurotrophic factors. J Anat. 1999;194 (Pt 1):1–14.
   PubMed Web of Science ®Google Scholar
• Piirsoo M, Kaljas A, Tamm K, Timmusk T. Expression of NGF and GDNF family members and their receptors during peripheral nerve development and differentiation of Schwann cells in vitro. Neurosci Lett. 2010;469:135–40.
   PubMed Web of Science ®Google Scholar
• Mufson EJ, Counts SE, Perez SE, Ginsberg SD. Cholinergic system during the progression of Alzheimer’s disease: therapeutic implications. Expert Rev Neurother. 2008;8:1703–18.
   PubMedGoogle Scholar
• De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N, et al.. Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice. Proc Natl Acad Sci USA. 2005;102:3811–6.
   PubMed Web of Science ®Google Scholar
• Bishop KM, Hofer EK, Mehta A, Ramirez A, Sun L, Tuszynski M, et al.. Therapeutic potential of CERE-110 (AAV2-NGF): targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neurons. Exp Neurol. 2008;211:574–84.
   PubMed Web of Science ®Google Scholar
• Wyman T, Rohrer D, Kirigiti P, Nichols H, Pilcher K, Nilaver G, et al.. Promoter-activated expression of nerve growth factor for treatment of neurodegenerative diseases. Gene Ther. 1999;6:1648–60.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH. Growth-factor gene therapy for neurodegenerative disorders. Lancet Neurol. 2002;1:51–57.
   PubMed Web of Science ®Google Scholar
• Hwang DH, Jeong SR, Kim BG. Gene transfer mediated by stem cell grafts to treat CNS injury. Expert Opin Biol Ther. 2011;11:1599–1610.
   PubMed Web of Science ®Google Scholar
• Kögler G, Sensken S, Airey JA, Trapp T, Müschen M, Feldhahn N, et al.. A new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential. J Exp Med. 2004;200:123–135.
   PubMed Web of Science ®Google Scholar
• Iwasaki H, Kawamoto A, Willwerth C, Horii M, Oyamada A, Akimaru H, et al.. Therapeutic potential of unrestricted somatic stem cells isolated from placental cord blood for cardiac repair post myocardial infarction. Arterioscler Thromb Vasc Biol. 2009;29:1830–5.
   PubMed Web of Science ®Google Scholar
• Schira J, Gasis M, Estrada V, Hendricks M, Schmitz C, Trapp T, et al.. Significant clinical, neuropathological and behavioural recovery from acute spinal cord trauma by transplantation of a well-defined somatic stem cell from human umbilical cord blood. Brain. 2012;135:431–46.
   PubMed Web of Science ®Google Scholar
• Trapp T, Kögler G, El-Khattouti A, Sorg RV, Besselmann M, Föcking M, et al.. Hepatocyte growth factor/c-MET axis-mediated tropism of cord blood-derived unrestricted somatic stem cells for neuronal injury. J Biol Chem. 2008;283:32244–53.
   PubMed Web of Science ®Google Scholar
• Iwaniuk KM, Schira J, Weinhold S, Jung M, Adjaye J, Müller HW, et al.. Network-like impact of MicroRNAs on neuronal lineage differentiation of unrestricted somatic stem cells from human cord blood. Stem Cells Dev. 2011;20:1383–94.
   PubMed Web of Science ®Google Scholar
• Fallahi-Sichani M, Soleimani M, Najafi SM, Kiani J, Arefian E, Atashi A. In vitro differentiation of cord blood unrestricted somatic stem cells expressing dopamine-associated genes into neuron-like cells. Cell Biol Int. 2007;31:299–303.
   PubMed Web of Science ®Google Scholar
• Longhi L, Watson DJ, Saatman KE, Thompson HJ, Zhang C, Fujimoto S, et al.. Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma. 2004;21:1723–36.
   PubMed Web of Science ®Google Scholar
• Lee HJ, Lim IJ, Park SW, Ko YB, Kim SU. Human neural stem cells genetically modified to express human nerve growth factor (NGF) gene restore cognition in mouse with ibotenic acid-induced cognitive dysfunction. Cell Transplant 2012. [Epub ahead of print]
   Google Scholar
• Kao S, Jaiswal RK, Kolch W, Landreth GE. Identification of the mechanisms regulating the differential activation of the mapk cascade by epidermal growth factor and nerve growth factor in PC12 cells. J Biol Chem. 2001;276:18169–77.
   PubMed Web of Science ®Google Scholar
• Hafizi M, Bakhshandeh B, Soleimani M, Atashi A. Exploring the enkephalinergic differentiation potential in adult stem cells for cell therapy and drug screening implications. In Vitro Cell Dev Biol Anim. 2012;48:562–9.
   PubMed Web of Science ®Google Scholar
• Tuszynski MH, Thal L, Pay M, Salmon DP, U HS, Bakay R, et al.. A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med. 2005;11:551–5.
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood. 2002;99:2214–20.
   PubMed Web of Science ®Google Scholar
• Snyder BR, Boulis NM, Federici T. Viral vector-mediated gene transfer for CNS disease. Expert Opin Biol Ther. 2010;10:381–94.
   PubMed Web of Science ®Google Scholar
• Ali H, Bahbahani H. Umbilical cord blood stem cells – potential therapeutic tool for neural injuries and disorders. Acta Neurobiol Exp (Wars). 2010;70:316–24.
   PubMed Web of Science ®Google Scholar
• Snyder EY, Senut MC. The use of nonneuronal cells for gene delivery. Neurobiol Dis. 1997;4:69–102.
   PubMed Web of Science ®Google Scholar
• Joers VL, Emborg ME. Preclinical assessment of stem cell therapies for neurological diseases. ILAR J. 2009;51:24–41.
   PubMed Web of Science ®Google Scholar